Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nitroprusside.

J N Cohn, L P Burke

    Annals of Internal Medicine
    |November 1, 1979
    PubMed
    Summary
    This summary is machine-generated.

    Sodium nitroprusside is an effective vasodilator for managing hypertension and heart failure. Its rapid action and tolerability make it ideal for short-term use, though prolonged infusions require careful monitoring.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Contamination of domestic groundwater systems by verotoxigenic escherichia coli (VTEC), 2003-2019: A global scoping review.

    Water research·2020
    Same author

    Effect of carvedilol, lisinopril and their combination on vascular and cardiac health in patients with borderline blood pressure: the DETECT Study.

    Journal of human hypertension·2012
    Same author

    Rationale for angiotensin II receptor blocker therapy in chronic heart failure.

    Journal of the renin-angiotensin-aldosterone system : JRAAS·2007
    Same author

    Relationship between C-reactive protein and arterial stiffness in an asymptomatic population.

    Journal of human hypertension·2005
    Same author

    Angiotensin receptor blockers and clinical trials in heart failure.

    European heart journal·2003
    Same author

    Ubiquinone does not rescue acute myeloid leukemia cells from growth inhibition by statins.

    Leukemia·2003
    Same journal

    Correction to I.M. Matters News: Sleep medicine for seniors.

    Annals of internal medicine·2026
    Same journal

    Adverse Events After Same-Day COVID-19 and Influenza Vaccination Versus Influenza Vaccination Alone : A Target Trial Emulation.

    Annals of internal medicine·2026
    Same journal

    Leveraging Real-World Evidence to Inform Regulatory, Clinical, and Coverage Decisions Related to Glucagon-Like Peptide-1-Based Therapies: Synopsis of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop.

    Annals of internal medicine·2026
    Same journal

    Methodological Approaches to Real-World Evidence Generation for Glucagon-like Peptide-1-Based Therapies: Synopsis of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop.

    Annals of internal medicine·2026
    Same journal

    Weekly and Biweekly Treatment With Bofanglutide Versus Semaglutide in Chinese Patients With Type 2 Diabetes : A Phase 2b Randomized Clinical Trial.

    Annals of internal medicine·2026
    Same journal

    Grappling with GLP-1 prescribing.

    Annals of internal medicine·2026
    See all related articles

    Area of Science:

    • Pharmacology
    • Cardiovascular Medicine

    Background:

    • Acute hypertension, heart failure, and vasoconstricted states require effective management.
    • Controlled hypotension is often necessary during surgical procedures.

    Purpose of the Study:

    • To evaluate sodium nitroprusside as a potent vasodilator for various cardiovascular conditions.
    • To assess its efficacy and tolerability in clinical settings.

    Main Methods:

    • Intravenous administration of sodium nitroprusside.
    • Dosage titration to achieve desired vascular dilation.
    • Monitoring of patient response and potential toxicity.

    Main Results:

    • Sodium nitroprusside demonstrated high efficacy and tolerability in managing acute hypertension and heart failure.

    Related Experiment Videos

  • It effectively induced controlled hypotension during surgery with rapid onset and offset.
  • Careful dosage titration ensured uniform effectiveness in achieving vascular dilation.

    • Conclusions:

    • Sodium nitroprusside is a leading vasodilator for short-term management of acute hypertensive and vasoconstricted states.
    • Its effectiveness and safety profile make it a valuable therapeutic agent.
    • It serves as a potential model for developing new oral vasodilators.